Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06479447 · ClinicalTrials.gov registry record · NA

Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder

A NA study of PTSD, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
17,000
Enrollment target
2
Study locations

NCT06479447 is a NA study of PTSD that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 17,000 participants, above the 192-participant average among 154 other PTSD trials with a reported enrollment target (8754% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06479447, a NA study of PTSD, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
17,000 participants
Enrollment target
2
Study locations

Study Summary

This study aims to implement and evaluate a more timely approach to post-traumatic stress disorder (PTSD) diagnosis and management, entitled Patient Outcome Reporting for Timely Assessments of Life with Post-Traumatic Stress Disorder (PORTAL-PTSD) in a primary care setting with a high prevalence of trauma, specifically the South Side of Chicago, in partnership with Chicago Family Health Center (CFHC).

Conditions Studied

Interventions

  • OTHER PORTAL-PTSD

Study Locations (2)

Illinois

  • CFHC South Chicago - Chicago
  • CFHC Chicago Lawn - Chicago

Trial Details

FieldValue
Enrollment Target 17,000 participants
Start Date 2024-07-15
Est. Completion 2026-07-14
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT06479447

The ClinicalTrials.gov registry entry for NCT06479447 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 17,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 192-participant average among 154 other PTSD trials with a reported enrollment target (8754% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which PORTAL-PTSD is the first listed.

NCT06479447 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06479447 about?

NCT06479447 is a clinical study titled "Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder". This study aims to implement and evaluate a more timely approach to post-traumatic stress disorder (PTSD) diagnosis and management, entitled Patient Outcome Reporting for Timely Assessments of Life with Post-Traumatic Stress Disorder (PORTAL-PTSD) in a primary care setting with a high prevalence of ...

What is the current status of trial NCT06479447?

This trial is currently recruiting. It is a NA study. The enrollment target is 17,000 participants. The study started on 2024-07-15. Estimated completion is 2026-07-14.

What conditions does trial NCT06479447 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT06479447?

The interventions under investigation include: PORTAL-PTSD (OTHER).

Who is sponsoring clinical trial NCT06479447?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06479447 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.